INAB: IN8BIO, INC. insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 0 sales totaling - in the last 180 days.
Activist and 5% holders
| Filed | What | Holder | Stake | Change | Filing |
|---|---|---|---|---|---|
| 2026-08-13 | 13G amendment | LYTTON LAURENCE W | 9.99% | SEC |
Institutional ownership (Q2 2026)
21 institutions reported holding $5.35M of IN8BIO, INC. on Form 13F (19 the quarter before). 3 opened a new position and 1 sold out. Shares held by institutions: +1%.
| Largest holders | Shares | Value |
|---|---|---|
| Alyeska Investment Group, L.P. | 944,319 | $1.33M |
| FRANKLIN RESOURCES INC | 914,531 | $1.29M |
| 683 Capital Management, LLC | 724,637 | $1.02M |
| Stonepine Capital Management, LLC | 695,287 | $980K |
| VANGUARD CAPITAL MANAGEMENT LLC | 88,865 | $127K |
| BIOS Capital Management, LP | 80,957 | $114K |
| GEODE CAPITAL MANAGEMENT, LLC | 72,550 | $102K |
| CITADEL ADVISORS LLC | 63,055 | $89K |
| OPPENHEIMER & CO INC | 63,042 | $89K |
| VANGUARD FIDUCIARY TRUST CO | 43,570 | $62K |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.